What is the response rate for ruxolitinib and azacitidine combination?

What response rate was reported for the ruxolitinib plus azacitidine combination?

The provided information does not include any clinical response-rate data for the ruxolitinib and azacitidine combination, so I can’t state a specific response rate from it.

Which response rate measure are you looking for (ORR vs CR vs overall survival)?

“Response rate” can mean different endpoints in clinical trials, such as:
- ORR (overall response rate)
- CR (complete response)
- CR/PL (complete response plus platelet recovery)
- hematologic improvement or other composite response definitions

If you tell me the exact study/trial (or the patient population, such as myelodysplastic syndromes, AML, or post-transplant relapse), I can align to the correct endpoint.

Can you share the trial name or source?

If you share the trial identifier (e.g., NCT number) or the text you’re working from, I can extract the reported response rate for ruxolitinib + azacitidine.